Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Topo Athletic Ultraventure 2 Trail-Running Shoes - Women's | REI Co-op
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry | npj Breast Cancer
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Patients with cancer achieve response to messenger RNA COVID-19 vaccine
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Pasireotide for malignant insulinoma
Stability and Transitions in Posttraumatic Growth Trajectories Among Cancer Patients: LCA and LTA Analyses
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
A genome‐wide CRISPR activation screen reveals Hexokinase 1 as a critical factor in promoting resistance to multi‐kinase inhibitors in hepatocellular carcinoma cells - Sofer - 2022 - The FASEB Journal - Wiley Online Library
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
A phase I clinical trial of dTCApFs, a derivative of a novel human hormone peptide, for the treatment of advanced/metastatic sol
PDF) Stability and Transitions in Posttraumatic Growth Trajectories Among Cancer Patients: LCA and LTA Analyses | Ruth Pat-Horenczyk, Leia Y Saltzman, Yaira Hamama-raz, Shlomit Perry, and Salomon Stemmer - Academia.edu
Transnational cancer research lab | Felsenstein Medical Research Center
